Back

ST Pharm lands record $66.135 million oligonucleotide API contract

Verifying
  • ST Pharm signed its largest-ever oligonucleotide API contract with a U.S.-based global biotech firm.
  • The $66.135 million deal lifted ST Pharm’s cumulative orders this year to at least 260 billion won.
  • ST Pharm plans to add production lines at its second oligonucleotide plant.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.